Vir Biotechnology, Inc. (VIR) Capital expenditures 2017–2025
Vir Biotechnology, Inc. (VIR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.8MFY2025 · since FY2017: $2.7M → $4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.8M | -33.8% |
| FY2024 | $7.3M | -66.2% |
| FY2023 | $21.6M | -68.3% |
| FY2022 | $68.0M | +211.7% |
| FY2021 | $21.8M | +233.1% |
| FY2020 | $6.5M | -26.7% |
| FY2019 | $8.9M | +9.1% |
| FY2018 | $8.2M | +198.8% |
| FY2017 | $2.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice